10-QThe Record
Janux Therapeutics, Inc. files 10-Q
Filed Nov 6, 2024 · 1y ago · Accession 0000950170-24-122370
Plain English
Quarterly report — three-month financials and management discussion.
Read the source below for the full document.
Filing details
- Company
- Janux Therapeutics, Inc.
- Ticker
- JANX
- CIK
- 1817713
- Form type
- 10-Q
- Filing date
- Nov 6, 2024
- Report date
- Sep 30, 2024
- Document
- janx-20240930.htm
- Size
- 9.2 MB